Evaluation Activities. The evaluation process used by the committee must include the following activities:
A. Completion by the probationer of required orientation activities, including reviews of (a) the duties and responsibilities of instructors, (b) guidelines for probationary review committees, and (c) departmental objectives, the probationer’s job description, and teaching and/or work assignment.
B. The teaching effectiveness professional development plan (see Appendix H) or the work plan (see 811.1) includes a set of long-range and quarterly goals with supporting activities, that are mutually agreed upon by the probationer and the probationary review committee. If mutual agreement cannot be reached, the vice president of instruction will make the final decision. In cases where major revision is desired, the goals and objectives should be re-submitted for approval. It is the responsibility of the committee to determine when an adjustment requires resubmission.
C. The collection and evaluation of quarterly Student Appraisals of Instruction using district evaluation forms developed under Article 803.1 or, in the case of non- teaching faculty, appraisal data collected from clients served;
D. Observations of probationer teaching in classroom, lab, online, hybrid, and/or clinical settings or, for non-teaching faculty, carrying out their duties;
E. Peer evaluations by the members of the probationer’s department, collected at least annually, utilizing a form mutually agreed upon by the District and the LCCFAHE. Faculty, staff, and other individuals may be added to the group participating in the probationer’s peer evaluation provided that they have sufficient interaction with the probationer, and a majority of the review committee members approve of the additions.
F. Attendance at one of each of the following committee or council meetings: Curriculum Committee, Instructional Assessment Committee, Academic Standards Committee, Instructional Council, Governance Council, and the College Board of Trustees. Meeting minutes listing the probationer’s name as a guest are suggested as a method of documenting progress.
G. Assessment by the probationer’s supervisor, reported at review committee meetings, reviewing general aspects of the probationer’s performance.
H. An annual written self-evaluation by the probationer assessing evaluation data, summarizing progress towards goals and objectives, and summarizing actions taken or contemplated in order to address areas of concern. Additional eval...
Evaluation Activities. During the Evaluation Period BCV shall, at its sole cost and expense, perform the validation, market analysis research and other activities described in the Development Plan with respect to Licensed Products in the Field and in the Territory to evaluate the Biofuel IP in order to determine BCV’s interest in obtaining the Commercialization License.
Evaluation Activities. 8.8.1. In preparing the Professional Activity Weight form, both the faculty member and the immediate supervisor will select one (1) tenured faculty member (not to include immediate family) each to serve as Faculty Peer Reviewers. Faculty Peer Reviewers must reside in the same Department, School, or College as the faculty member being evaluated. If all tenured faculty within a College will have to complete more than four (4) peer evaluations per year the faculty member being evaluated and Xxxx may select peer reviewers from another College.
8.8.2. By May 15th, the faculty member shall submit the Professional Activities Report to the immediate supervisor and Faculty Peer Reviewers. The immediate supervisor and the Faculty Peer Reviewers will have until June 1st to complete the Professional Activities Weighting form and associated forms.
8.8.3. All material will be returned to the faculty member for preparation of the Evaluation Narrative (Appendix C5). The faculty member has until July 1st to submit the Evaluation Narrative to his or her immediate supervisor.
8.8.4. The immediate supervisor has until August 1st to generate the Summative Evaluation Report.
Evaluation Activities. All Exploration Operations carried out by Contractor in the vicinity of a Hydrocarbon Discovery to appraise the total area and importance of the discovery including, but not limited to extension or appraisal xxxxx, detailed seismic lines; geological, geochemical, gravimetric and magnetic studies; interpretation of well logs, formation tests and other data obtained from the drilling of said xxxxx. One.Three.
Evaluation Activities. To assess the viability of SCH 58500 Ad-p53 (Reference: U.S. IND #6754), MULTIVIR shall perform the following: Expression of SCH 58500 Ad-53: • Use Technology to express SCH 5800 Ad-53 for use in the Assays specified below • Procedural Ref for determination of viral particle concentration: X.X. Xxxxxxx et al, HUMAN GENE THERAPY 8:453-465 (March 1, 1997) Assays: • Adenoviral vector titer (IU/ml) • Adenoviral vector particle number (vp) concentration • p53 protein expression: dose-response. Includes adenovirus stability testing • Inhibition of cell proliferation: dose-response
Evaluation Activities. 1. Program evaluators may contact me periodically in discharging their duty to conduct evaluation activities regarding my experiences through the Program. I am required to participate willingly and in good faith in these evaluation activities.
2. By signing this agreement, I hereby give consent to be contacted by evaluators for the purpose of conducting reasonable evaluation efforts and consent to participate in such efforts.
3. I agree to provide a Program administrator with permanent and updated contact information and permit contact for the purpose of evaluations during my degree enrollment.
4. I agree to provide a Program administrator with permanent and updated contact information and permit contact for the purpose of Program evaluations of my post-graduation experience during and after completion of my employment service period.
5. Upon graduation, I agree to act as a mentor to future program students, if requested by a Program administrator.
Evaluation Activities. 2.1 Provision of Information regarding Evaluation Compounds. PTC shall provide the following information to B&L to the extent available for each Evaluation Compound promptly following B&L's request with respect to the first group of Evaluation Compounds to be evaluated and then within [**] following B&L's request with regard to subsequent groups of Evaluation Compounds to be evaluated, provided that such requests with regard to subsequent groups of Evaluation Compounds may occur no more often than [**] and no more often than [**] during the Initial Term and [**] during the Extension Term:
(a) PTC Compound Number ([**]);
(b) molecular weight;
(c) chemical name and structure, including calculated 2D and 3D molecular features; provided, however, that (i) chemical names and structures for PTC Program Compounds shall only be provided for inspection at PTC's offices until such time as specific compounds are selected for evaluation by B&L, at which time the names and structures of only those compounds selected will be provided, and (ii) chemical names and structures for PTC Development Compounds shall not be provided until after the in vitro screening proposed by B&L is complete, and then only for those PTC Development Compounds actually screened and for which B&L submits a written notice of continued interest;
(d) [**];
(e) [**];
(f) [**];
(g) [**];
(h) a summary description of the government grants received by PTC in support of its research and development efforts relating to any Evaluation Compounds;
(i) any additional Applicable Know-How that would reasonably be expected to be material to B&L's evaluation of the Evaluation Compounds; provided, however, that such additional Applicable Know-How shall only be provided for inspection at PTC's offices until such time as specific Evaluation Compounds are selected for evaluation by B&L; and
(j) information regarding any of the following of which PTC becomes aware following the Effective Date: (i) patent or other intellectual property rights owned or controlled by any third party that would be infringed by such Evaluation Compound or B&L's exercise of the evaluation license granted under Section 4.1 in accordance with this Agreement; (ii) any claims made against PTC asserting the invalidity, unenforceability, abuse or misuse of any of the Applicable Know-How or Applicable Patents; (iii) any claim made by PTC of any violation or infringement or misappropriation by others of PTC's rights in an Evaluation Compound, or t...
Evaluation Activities. 2.17.9.1. DMAS, CMS and its designated agent(s) will conduct periodic evaluations of the Demonstration over time from multiple perspectives using both quantitative and qualitative methods.
2.17.9.2. The evaluations will be used for program improvement purposes and to assess the Demonstration’s overall impact on various outcomes including (but not limited to) enrollment/disenrollment patterns, beneficiary access and quality of care experiences, utilization and costs by service type (e.g., inpatient, outpatient, home health, prescription drugs, nursing facility, and home and community based waiver), and program staff and provider experiences.
2.17.9.3. As such, the evaluations will include surveys, site visits, analysis of claims and encounter data, focus groups, key informant interviews, and document reviews. The Contractor shall participate in evaluation activities as directed by CMS and/or DMAS and provide information or data upon request.
Evaluation Activities. 26.1 The Provider agrees that:
(a) the Department may conduct evaluation activities for the purposes of evaluating the Services including, but not limited to:
(i) monitoring, measuring and evaluating the Services, including through Customer satisfaction surveys;
(ii) the Provider being interviewed by the Department or its nominee;
(iii) the Provider giving the Department or its nominee access to the Provider’s premises and records in accordance with clause 40 [Access to Premises and Records]; and
(b) it will assist the Department or its nominee in carrying out these and any other evaluation activities which the Department requires to be undertaken, including any review and final evaluation of the Services.
Evaluation Activities. 4.1. The Participant shall make certain that the Products covered by the ASTM approval at all times conform to the ASTM Procedures and the ASTM Standard upon which the Product was approved.
4.2. Participant agrees that if it makes changes to its manufacturing process, quality control, and/or inspection procedures or changes the specifications for the Product, it will notify USDA immediately and will warrant that all future Products are still in conformance with the Program requirements to which they were tested.
4.3. If at any time ASTM is notified that the Product shall fail to conform to the processes, standards of quality, and specifications as set forth in Program and ASTM Procedures, ASTM shall so notify USDA and the Participant.
